ClinicalTrials.govpublic full text
Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma
glioblastoma, gliosarcoma, adult grade i meningioma, adult grade ii meningioma, adult grade iii meningioma, adult papillary meningioma, adult anaplastic meningioma, recurrent adult brain tumor, glioblastoma multiforme (gbm), imatinib, imatinib mesylate, hydroxyurea
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1030000
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.